Logo image of TUB.BR

FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

EBR:TUB - Euronext Brussels - BE0003823409 - Common Stock - Currency: EUR

137.2  +1.2 (+0.88%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TUB. TUB was compared to 52 industry peers in the Pharmaceuticals industry. The financial health of TUB is average, but there are quite some concerns on its profitability. TUB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TUB had positive earnings in the past year.
In the past year TUB has reported a negative cash flow from operations.
TUB had positive earnings in each of the past 5 years.
In the past 5 years TUB always reported negative operating cash flow.
TUB.BR Yearly Net Income VS EBIT VS OCF VS FCFTUB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of TUB (4.67%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 4.90%, TUB is in line with its industry, outperforming 40.38% of the companies in the same industry.
Industry RankSector Rank
ROA 4.67%
ROE 4.9%
ROIC N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
TUB.BR Yearly ROA, ROE, ROICTUB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

TUB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TUB.BR Yearly Profit, Operating, Gross MarginsTUB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

5

2. Health

2.1 Basic Checks

TUB has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, TUB has more shares outstanding
Compared to 1 year ago, TUB has an improved debt to assets ratio.
TUB.BR Yearly Shares OutstandingTUB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TUB.BR Yearly Total Debt VS Total AssetsTUB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TUB has an Altman-Z score of 41.79. This indicates that TUB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 41.79, TUB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for TUB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 41.79
ROIC/WACCN/A
WACCN/A
TUB.BR Yearly LT Debt VS Equity VS FCFTUB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

TUB has a Current Ratio of 0.02. This is a bad value and indicates that TUB is not financially healthy enough and could expect problems in meeting its short term obligations.
TUB has a Current ratio of 0.02. This is amonst the worse of the industry: TUB underperforms 92.31% of its industry peers.
A Quick Ratio of 0.02 indicates that TUB may have some problems paying its short term obligations.
TUB has a Quick ratio of 0.02. This is amonst the worse of the industry: TUB underperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
TUB.BR Yearly Current Assets VS Current LiabilitesTUB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

TUB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.57%.
The earnings per share for TUB have been decreasing by -20.68% on average. This is quite bad
Looking at the last year, TUB shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)3.57%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.9%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TUB.BR Yearly Revenue VS EstimatesTUB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M 250M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 67.92 indicates a quite expensive valuation of TUB.
Compared to the rest of the industry, the Price/Earnings ratio of TUB indicates a slightly more expensive valuation: TUB is more expensive than 67.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, TUB is valued quite expensively.
Industry RankSector Rank
PE 67.92
Fwd PE N/A
TUB.BR Price Earnings VS Forward Price EarningsTUB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TUB.BR Per share dataTUB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.53%, TUB is not a good candidate for dividend investing.
TUB's Dividend Yield is comparable with the industry average which is at 3.00.
With a Dividend Yield of 0.53, TUB pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

On average, the dividend of TUB grows each year by 7.33%, which is quite nice.
Dividend Growth(5Y)7.33%
Div Incr Years0
Div Non Decr Years0
TUB.BR Yearly Dividends per shareTUB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

TUB pays out 47.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP47.72%
EPS Next 2YN/A
EPS Next 3YN/A
TUB.BR Yearly Income VS Free CF VS DividendTUB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M
TUB.BR Dividend Payout.TUB.BR Dividend Payout, showing the Payout Ratio.TUB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

FINANCIERE DE TUBIZE

EBR:TUB (7/10/2025, 5:22:55 PM)

137.2

+1.2 (+0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-22 2025-03-22
Earnings (Next)08-02 2025-08-02
Inst Owners2.69%
Inst Owner ChangeN/A
Ins Owners33.27%
Ins Owner ChangeN/A
Market Cap6.11B
Analysts83.33
Price Target186.41 (35.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly Dividend0.97
Dividend Growth(5Y)7.33%
DP47.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 67.92
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.32
P/tB 3.32
EV/EBITDA N/A
EPS(TTM)2.02
EY1.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS41.35
TBVpS41.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.67%
ROE 4.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 41.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.57%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.98%
OCF growth 3YN/A
OCF growth 5YN/A